Literature DB >> 14232953

SPLENECTOMY FOR AGNOGENIC MYELOID METAPLASIA AND MYELOFIBROSIS.

N FISHMAN, W F BALLINGER.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX HORMONES; ANEMIA, APLASTIC; ANEMIA, HEMOLYTIC; BLOOD TRANSFUSION; CLASSIFICATION; CORTICOTROPIN, THERAPEUTIC; ERYTHROPOIESIS; MYELOFIBROSIS; MYELOID METAPLASIA; PATHOLOGY; SPLENECTOMY; SPLENOMEGALY

Mesh：

Substances：

Year:  1965        PMID： 14232953     DOI： 10.1001/archsurg.1965.01320080064015

Source DB:  PubMed          Journal:  Arch Surg        ISSN： 0004-0010


× No keyword cloud information.
  5 in total

Review 1.  [Myelofibrosis (author's transl)].

Authors:  W Hunstein; C Hauswaldt
Journal:  Klin Wochenschr       Date:  1974-04-01

2.  Compelling splenectomy in medically compromised patients.

Authors:  J J Bergin; T F Zuck; R E Miller
Journal:  Ann Surg       Date:  1973-12       Impact factor: 12.969

3.  Agnogenic myeloid metaplasia: role of splenectomy.

Authors:  C Marks; M Ahmadi
Journal:  Postgrad Med J       Date:  1969-04       Impact factor: 2.401

4.  Splenectomy for myeloproliferative disorders.

Authors:  R E Wilson; D S Rosenthal; W C Moloney; R T Osteen
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

5.  Splenectomy in myeloid metaplasia.

Authors:  E B Cabot; M F Brennan; D S Rosenthal; R E Wilson
Journal:  Ann Surg       Date:  1978-01       Impact factor: 12.969
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.